Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Serosurveillance remains a valuable yet underutilized tool. Through the KEMIS project, KWTRP aim to demonstrate the value of multi-pathogen serosurveillance in Kenya.

researcher pipetting a solution into a tube © University of Oxford Images / Public Affairs Directorate

Since 2021, we have conducted serosurveys among populations residing within health and demographic surveillance sites in Kilifi, Nairobi, Kisumu and Siaya. Samples collected during the surveys are tested for IgG antibodies using cutting edge assays such as a multiplex vaccine-preventable disease panel (diphtheria, pertussis, tetanus, measles, mumps, rubella, varicella) and an arbovirus multiplex panel (chikungunya, dengue, and Rift Valley Fever).

8th May, the KEMIS Steering Committee reviewed the progress, findings, and achievements of the Project. On 9th May we held a Dissemination Workshop with representation from a wide range of stakeholders including the Ministry of Health, Kilifi, Nairobi, Kiambu, Laikipia and Machakos Counties. We shared findings from the KEMIS project and received valuable input from the delegates including recommendations on potential approaches for expanding the reach and sustainability of serosurveillance in Kenya.